A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

NCT03953235 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Colorectal Cancer
Pancreatic Cancer
Solid Tumor
Shared Neoantigen-Positive Solid Tumors

Interventions

BIOLOGICAL: GRT-C903
BIOLOGICAL: GRT-R904
BIOLOGICAL: nivolumab
BIOLOGICAL: ipilimumab

Sponsor

Gritstone bio, Inc.

Collaborators

[object Object]